DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Poynard T, Shiff E, Terg R. et al.
Sustained virologic response (SVR) in the EPIC3 trial: week twelve virology predicts SVR in previous interferon/ribavirin treatment failures receiving PEG-Intron/Rebetol (PR) weight based dosing (WBD).
J Hepatol 2005; 42 (Suppl 2): 40A-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.